3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
4
Stomach Neoplasms
2
Cardiovascular Diseases
2
Recurrence
1
Pulmonary Embolism
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Hemorrhage
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Blood Specimen Collection
6
Surveys and Questionnaires
5
Observation
3
Colonoscopy
3
Biopsy
3
Remote Patient Monitoring
2
Nivolumab
2
Interviews as Topic
2
Gastroscopy
2
trastuzumab deruxtecan
1
s-formylglutathione hydrolase
1
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
Videotape Recording
1
Validation Studies as Topic
1
Ultrasonography
1
Tomography, X-Ray Computed
1
Standard of Care
1
Specimen Handling
1
Single-Balloon Enteroscopy
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy
1
Quality of Life
1
Proctectomy
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Lutetium-177
1
Lutetium
1
Induction Chemotherapy
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Gastrointestinal Neoplasms
×
Aspirin
×
Clear all
NCT04081831
2022-04-19
ENgAGE-HK
Bayer
Completed
99,999 enrolled